[HTML][HTML] Therapeutic host-directed strategies to improve outcome in tuberculosis

C Young, G Walzl, N Du Plessis - Mucosal immunology, 2020 - Elsevier
Abstract Bacille Calmette-Guérin (BCG) is the only licenced tuberculosis (TB) vaccine, but
has limited efficacy against pulmonary TB disease development and modest protection …

The pathogenesis of tuberculous meningitis

AG Davis, UK Rohlwink, A Proust… - Journal of leukocyte …, 2019 - academic.oup.com
Tuberculosis (TB) remains a leading cause of death globally. Dissemination of TB to the
brain results in the most severe form of extrapulmonary TB, tuberculous meningitis (TBM) …

Host-directed therapies: modulating inflammation to treat tuberculosis

S Krug, S Parveen, WR Bishai - Frontiers in immunology, 2021 - frontiersin.org
Following infection with Mycobacterium tuberculosis, the causative agent of tuberculosis
(TB), most human hosts are able to contain the infection and avoid progression to active TB …

The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy

C Stek, B Allwood, NF Walker, RJ Wilkinson… - Frontiers in …, 2018 - frontiersin.org
Impaired lung function is common in people with a history of tuberculosis. Host-directed
therapy added to tuberculosis treatment may reduce lung damage and result in improved …

Targeting molecular inflammatory pathways in granuloma as host-directed therapies for tuberculosis

R Guler, M Ozturk, S Sabeel, B Motaung… - Frontiers in …, 2021 - frontiersin.org
Globally, more than 10 million people developed active tuberculosis (TB), with 1.4 million
deaths in 2020. In addition, the emergence of drug-resistant strains in many regions of the …

The interplay between systemic inflammation, oxidative stress, and tissue remodeling in tuberculosis

EP Amaral, CL Vinhaes… - Antioxidants & redox …, 2021 - liebertpub.com
Significance: Excessive and prolonged proinflammatory responses are associated with
oxidative stress, which is commonly observed during chronic tuberculosis (TB). Such …

Neutrophils in tuberculosisâ   first line of defence or booster of disease and targets for host-directed therapy?

T Dallenga, UE Schaible - FEMS Pathogens and Disease, 2016 - academic.oup.com
Necrotizing granulomas, exacerbating pathogenesis and neutrophil influx at the site of
infection are hallmarks of active pulmonary tuberculosis (TB) in humans. The role of …

Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide

S Krug, M Gupta, P Kumar, L Feller, EA Ihms… - Nature …, 2023 - nature.com
The antibiotic pyrazinamide (PZA) is a cornerstone of tuberculosis (TB) therapy that shortens
treatment durations by several months despite being only weakly bactericidal. Intriguingly …

Tuberculosis: an update on pathophysiology, molecular mechanisms of drug resistance, newer anti-TB drugs, treatment regimens and host-directed therapies

P Borah, PK Deb, KN Venugopala… - Current Topics in …, 2021 - ingentaconnect.com
Human tuberculosis (TB) is primarily caused by Mycobacterium tuberculosis (Mtb) that
inhabits inside and amidst immune cells of the host with adapted physiology to regulate …

Recent advances in host-directed therapies for tuberculosis and malaria

KC Matteucci, AAS Correa, DL Costa - Frontiers in Cellular and …, 2022 - frontiersin.org
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, and malaria,
caused by parasites from the Plasmodium genus, are two of the major causes of death due …